KNSA logo

KNSA Cash From Investing

Annual CFI:

$37.67M+$67.23M(+227.46%)
December 31, 2024

Summary

  • As of today, KNSA annual cash from investing is $37.67 million, with the most recent change of +$67.23 million (+227.46%) on December 31, 2024.
  • During the last 3 years, KNSA annual cash from investing has fallen by -$90.96 million (-70.71%).
  • KNSA annual cash from investing is now -70.71% below its all-time high of $128.63 million, reached on December 31, 2021.

Performance

1-Year Change

+227.46%

3-Year Change

-70.71%

5-Year Change

-23.45%

15-Year Change

+54697.1%

KNSA Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

89.29%
KNSA annual cash from investing is higher than 89.29% of companies in Healthcare sector

Range

All-Time High

$128.63M
KNSA annual cash from investing is currently -70.71% below its historical high of $128.63 million

3-Year Low

-$29.56M
KNSA annual cash from investing is currently +227.46% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
KNSA previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Mar 3, 2026
KNSA next annual earnings announcement is scheduled for Mar 3, 2026

OtherKNSAcash flow metrics

Annual CFF

$12.27M
KNSA annual cash from financing is $12.27 million

Annual CFO

$25.69M
KNSA annual cash from operations is $25.69 million

Annual FCF

$25.41M
KNSA annual free cash flow is $25.41 million

Annual CAPEX

$277.00K
KNSA annual capital expenditures is $277.00 thousand

Quarterly CFI:

-$62.76M-$58.87M(-1516.15%)
September 30, 2025

Summary

  • As of today, KNSA quarterly cash from investing is -$62.76 million, with the most recent change of -$58.87 million (-1516.15%) on September 30, 2025.
  • Over the past year, KNSA quarterly cash from investing has dropped by -$56.41 million (-888.58%).
  • KNSA quarterly cash from investing is now -170.68% below its all-time high of $88.79 million, reached on March 31, 2020.

Performance

3-Month Change

-1516.15%

1-Year Change

-888.58%

3-Year Change

-429.6%

5-Year Change

+58.07%

KNSA Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

10.98%
KNSA quarterly cash from investing is higher than 10.98% of companies in Healthcare sector

Range

All-Time High

$88.79M
KNSA quarterly cash from investing is currently -170.68% below its historical high of $88.79 million

3-Year Low

-$62.76M
KNSA quarterly cash from investing is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
KNSA previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 3, 2026
KNSA next earnings announcement is scheduled for Mar 3, 2026

OtherKNSAcash flow metrics

Quarterly CFF

$11.90M
KNSA quarterly cash from financing is $11.90 million

Quarterly CFO

$33.68M
KNSA quarterly cash from operations is $33.68 million

Quarterly FCF

$33.01M
KNSA quarterly free cash flow is $33.01 million

Quarterly CAPEX

$671.00K
KNSA quarterly capital expenditures is $671.00 thousand

TTM CFI:

-$52.89M-$56.41M(-1602.02%)
September 30, 2025

Summary

  • As of today, KNSA TTM cash from investing is -$52.89 million, with the most recent change of -$56.41 million (-1602.02%) on September 30, 2025.
  • Over the past year, KNSA TTM cash from investing has dropped by -$10.37 million (-24.39%).
  • KNSA TTM cash from investing is now -121.38% below its all-time high of $247.32 million, reached on September 30, 2021.

Performance

3-Month Change

-1602.02%

1-Year Change

-24.39%

3-Year Change

-242.1%

5-Year Change

+41.35%

KNSA TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

21.43%
KNSA TTM cash from investing is higher than 21.43% of companies in Healthcare sector

Range

All-Time High

$247.32M
KNSA TTM cash from investing is currently -121.38% below its historical high of $247.32 million

3-Year Low

-$57.32M
KNSA TTM cash from investing is currently +7.74% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
KNSA previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 3, 2026
KNSA next earnings announcement is scheduled for Mar 3, 2026

OtherKNSAcash flow metrics

TTM CFF

$27.51M
KNSA TTM cash from financing is $27.51 million

TTM CFO

$102.86M
KNSA TTM cash from operations is $102.86 million

TTM FCF

$101.73M
KNSA TTM free cash flow is $101.73 million

TTM CAPEX

$1.13M
KNSA TTM capital expenditures is $1.13 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

KNSA Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+227.5%-888.6%-24.4%
3Y3 Years-70.7%-429.6%-242.1%
5Y5 Years-23.4%+58.1%+41.4%

KNSA Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-70.7%+227.5%-196.1%at low-240.4%+7.7%
5Y5-Year-70.7%+227.5%-173.0%+58.1%-121.4%+41.4%
All-TimeAll-Time-70.7%+115.8%-170.7%+67.8%-121.4%+80.3%

KNSA Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$62.76M(-1516.1%)
-$52.89M(-1602.0%)
Jun 2025
-
-$3.88M(+92.5%)
$3.52M(+108.9%)
Mar 2025
-
-$51.54M(-178.9%)
-$39.39M(-204.6%)
Dec 2024
$37.67M(+227.5%)
$65.29M(+1128.6%)
$37.67M(+188.6%)
Sep 2024
-
-$6.35M(+86.4%)
-$42.52M(+12.2%)
Jun 2024
-
-$46.80M(-283.3%)
-$48.44M(-243.0%)
Mar 2024
-
$25.52M(+271.4%)
$33.89M(+214.6%)
Dec 2023
-$29.56M(-265.9%)
-$14.89M(-21.3%)
-$29.56M(+48.4%)
Sep 2023
-
-$12.28M(-134.6%)
-$57.32M(-120.4%)
Jun 2023
-
$35.53M(+193.7%)
-$26.01M(-11.7%)
Mar 2023
-
-$37.92M(+11.1%)
-$23.27M(-188.1%)
Dec 2022
-$8.08M(-106.3%)
-$42.66M(-324.1%)
-$8.08M(+47.7%)
Sep 2022
-
$19.04M(-50.2%)
-$15.46M(-215.8%)
Jun 2022
-
$38.27M(+268.4%)
$13.35M(-78.1%)
Mar 2022
-
-$22.72M(+54.6%)
$61.08M(-52.5%)
Dec 2021
$128.63M
-$50.04M(-204.6%)
$128.63M(-48.0%)
Sep 2021
-
$47.85M(-44.4%)
$247.32M(+396.5%)
Jun 2021
-
$85.99M(+91.8%)
$49.81M(+173.9%)
DateAnnualQuarterlyTTM
Mar 2021
-
$44.83M(-34.7%)
-$67.40M(-187.5%)
Dec 2020
-$23.44M(-147.6%)
$68.64M(+145.9%)
-$23.44M(+74.0%)
Sep 2020
-
-$149.66M(-379.4%)
-$90.17M(-220.7%)
Jun 2020
-
-$31.22M(-135.2%)
$74.70M(-49.3%)
Mar 2020
-
$88.79M(+4534.1%)
$147.28M(+199.3%)
Dec 2019
$49.21M(+120.6%)
$1.92M(-87.4%)
$49.21M(-36.1%)
Sep 2019
-
$15.21M(-63.2%)
$76.96M(+157.8%)
Jun 2019
-
$41.36M(+545.8%)
-$133.13M(+46.4%)
Mar 2019
-
-$9.28M(-131.3%)
-$248.40M(-3.8%)
Dec 2018
-$239.20M(>-9900.0%)
$29.66M(+115.2%)
-$239.20M(+11.0%)
Sep 2018
-
-$194.87M(-163.7%)
-$268.86M(-263.2%)
Jun 2018
-
-$73.91M(>-9900.0%)
-$74.02M(>-9900.0%)
Mar 2018
-
-$75.00K(-1775.0%)
-$126.00K(-82.6%)
Dec 2017
-$69.00K(-2200.0%)
-$4000.00(+85.7%)
-$69.00K(-6.2%)
Sep 2017
-
-$28.00K(-47.4%)
-$65.00K(-75.7%)
Jun 2017
-
-$19.00K(-5.6%)
-$37.00K(-105.6%)
Mar 2017
-
-$18.00K
-$18.00K
Dec 2016
-$3000.00
-
-

FAQ

  • What is Kiniksa Pharmaceuticals International, plc annual cash from investing?
  • What is the all-time high annual cash from investing for Kiniksa Pharmaceuticals International, plc?
  • What is Kiniksa Pharmaceuticals International, plc annual cash from investing year-on-year change?
  • What is Kiniksa Pharmaceuticals International, plc quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Kiniksa Pharmaceuticals International, plc?
  • What is Kiniksa Pharmaceuticals International, plc quarterly cash from investing year-on-year change?
  • What is Kiniksa Pharmaceuticals International, plc TTM cash from investing?
  • What is the all-time high TTM cash from investing for Kiniksa Pharmaceuticals International, plc?
  • What is Kiniksa Pharmaceuticals International, plc TTM cash from investing year-on-year change?

What is Kiniksa Pharmaceuticals International, plc annual cash from investing?

The current annual cash from investing of KNSA is $37.67M

What is the all-time high annual cash from investing for Kiniksa Pharmaceuticals International, plc?

Kiniksa Pharmaceuticals International, plc all-time high annual cash from investing is $128.63M

What is Kiniksa Pharmaceuticals International, plc annual cash from investing year-on-year change?

Over the past year, KNSA annual cash from investing has changed by +$67.23M (+227.46%)

What is Kiniksa Pharmaceuticals International, plc quarterly cash from investing?

The current quarterly cash from investing of KNSA is -$62.76M

What is the all-time high quarterly cash from investing for Kiniksa Pharmaceuticals International, plc?

Kiniksa Pharmaceuticals International, plc all-time high quarterly cash from investing is $88.79M

What is Kiniksa Pharmaceuticals International, plc quarterly cash from investing year-on-year change?

Over the past year, KNSA quarterly cash from investing has changed by -$56.41M (-888.58%)

What is Kiniksa Pharmaceuticals International, plc TTM cash from investing?

The current TTM cash from investing of KNSA is -$52.89M

What is the all-time high TTM cash from investing for Kiniksa Pharmaceuticals International, plc?

Kiniksa Pharmaceuticals International, plc all-time high TTM cash from investing is $247.32M

What is Kiniksa Pharmaceuticals International, plc TTM cash from investing year-on-year change?

Over the past year, KNSA TTM cash from investing has changed by -$10.37M (-24.39%)
On this page